{"gene":"SGSM2","run_date":"2026-06-10T07:46:31","timeline":{"discoveries":[{"year":2007,"finding":"SGSM2 (and family members SGSM1/3) co-precipitate with RAP and RAB subfamily members of the small G protein superfamily, indicating physical association with these GTPases; endogenous Sgsm1 protein was localized to the trans-Golgi network by immunofluorescence microscopy in mouse Neuro2a cells.","method":"Immunoprecipitation (co-IP) of expressed cDNA constructs; immunofluorescence microscopy","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, co-IP demonstrated physical interaction with RAP/RAB GTPases and TGN localization shown by immunofluorescence, but no in vitro biochemical reconstitution or functional mutagenesis performed","pmids":["17509819"],"is_preprint":false},{"year":2011,"finding":"RUTBC1 (SGSM2) binds Rab9A-GTP both in vitro and in cultured cells but is NOT a GAP for Rab9A. Instead, RUTBC1 functions as a GAP for Rab32 and Rab33B, stimulating GTP hydrolysis; catalysis requires Arg-803, consistent with a dual-finger mechanism. RUTBC1 also influenced Rab32 binding to its effector Varp in cells.","method":"In vitro GTPase activity assays with biochemical screening of Rab substrates; active-site mutagenesis (Arg-803); co-immunoprecipitation in cells and cell extracts; catalytically-inhibited Rab33B Q92A mutant rescue experiment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution of GAP activity, active-site mutagenesis identifying catalytic residue, and cellular validation of Rab32 effector binding in a single rigorous study","pmids":["21808068"],"is_preprint":false},{"year":2015,"finding":"RUTBC1 (SGSM2) functions as a physiological GAP for both Rab32 and Rab38 in melanocytes, regulating the trafficking of all three melanogenic enzymes (tyrosinase, Tyrp1, and dopachrome tautomerase) to melanosomes. Rab9A interaction regulates RUTBC1 localization and is required for proper melanogenic enzyme trafficking. Either excess activation or inactivation of Rab32/38 (by manipulating RUTBC1 levels) impairs melanogenic enzyme trafficking.","method":"In vitro GAP assays; loss-of-function and gain-of-function manipulations in mouse melanocytes with readout of melanogenic enzyme localization; assessment of RUTBC1 localization dependence on Rab9A","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — physiological GAP role established by multiple functional assays in melanocytes, independently extending and replicating the in vitro findings of the 2011 JBC paper","pmids":["26620560"],"is_preprint":false},{"year":2019,"finding":"SGSM2 is a plasma membrane protein that directly interacts with E-cadherin and β-catenin. SGSM2 downregulation increased phosphorylation of FAK (Y576/577), decreased expression of epithelial markers (E-cadherin, β-catenin, Paxillin), and increased mesenchymal markers (Snail, Twist-1), reducing cell adhesion and promoting cancer cell migration. Oestrogen and fibronectin treatment promoted co-localization of SGSM2 at the leading edge with phospho-FAK (Y397).","method":"Interaction: co-immunoprecipitation, co-localization by immunofluorescence; loss-of-function knockdown with readout of EMT markers and cell migration assays","journal":"Cell adhesion & migration","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, co-IP and knockdown with multiple marker readouts, but no in vitro reconstitution or structural validation","pmids":["30744493"],"is_preprint":false},{"year":2022,"finding":"SGSM2 interacts with RAP1 and augments RAP1 activity. Activated RAP1 competitively suppresses RAS activation, thereby downregulating MAPK/ERK and PI3K/Akt signaling in thyroid cancer cells harboring wild-type RAS. Ectopic SGSM2 expression inhibited cell proliferation, migration, invasion, and tumorigenic activity in these cells.","method":"Co-immunoprecipitation to show SGSM2-RAP1 interaction; RAP1 activity assays; gain-of-function overexpression with readout of RAS activation, MAPK/ERK, PI3K/Akt signaling, and cancer cell phenotypes","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, co-IP plus GTPase activity assays and downstream pathway measurements, but no in vitro reconstitution or structural validation","pmids":["35264562"],"is_preprint":false}],"current_model":"SGSM2 (RUTBC1) is a RUN- and TBC-domain-containing protein that acts as a GTPase-activating protein (GAP) for Rab32, Rab33B, and Rab38 (requiring catalytic Arg-803 via a dual-finger mechanism), binds Rab9A-GTP as an effector to regulate its own localization, controls melanogenic enzyme trafficking to melanosomes, interacts with RAP1 to enhance its activity and thereby competitively suppress RAS/MAPK/PI3K signaling, and associates with E-cadherin/β-catenin at the plasma membrane to modulate cell adhesion and migration."},"narrative":{"mechanistic_narrative":"SGSM2 (RUTBC1) is a RUN- and TBC-domain protein that operates as a GTPase-activating protein (GAP) governing Rab-dependent membrane trafficking, with additional roles in small-G-protein signaling at the plasma membrane [PMID:21808068, PMID:35264562]. Biochemically, it stimulates GTP hydrolysis on Rab32 and Rab33B (and Rab38), with catalysis requiring Arg-803 via a dual-finger mechanism, while binding Rab9A-GTP as an effector rather than acting as its GAP [PMID:21808068]. Through this GAP activity it sets the activation state of Rab32/Rab38 in melanocytes, where its Rab9A-dependent localization controls trafficking of the melanogenic enzymes tyrosinase, Tyrp1, and dopachrome tautomerase to melanosomes; both excess activation and inactivation of Rab32/38 disrupt this trafficking [PMID:26620560]. SGSM2 additionally localizes to the plasma membrane, where it associates with E-cadherin and β-catenin to maintain epithelial adhesion and restrain FAK phosphorylation and EMT-associated migration [PMID:30744493], and binds RAP1 to augment its activity, competitively suppressing RAS/MAPK/ERK and PI3K/Akt signaling and tumorigenic behavior in cancer cells [PMID:35264562].","teleology":[{"year":2007,"claim":"Established that SGSM2 physically associates with the small-G-protein superfamily, placing it as a candidate regulator of RAP and RAB GTPases rather than an isolated protein.","evidence":"Co-IP of expressed cDNA constructs and immunofluorescence (family member Sgsm1 at the trans-Golgi network) in mouse Neuro2a cells","pmids":["17509819"],"confidence":"Medium","gaps":["Did not determine whether the association reflects GAP, effector, or scaffold function","No catalytic or in vitro reconstitution data","Localization shown for the Sgsm1 paralog, not SGSM2 directly"]},{"year":2011,"claim":"Defined the biochemical identity of SGSM2 as a GAP, resolving which Rabs it acts on versus binds and pinpointing the catalytic residue.","evidence":"In vitro GTPase assays with Rab substrate screening, Arg-803 active-site mutagenesis, and cellular co-IP showing Rab9A-GTP binding and effects on Rab32-Varp binding","pmids":["21808068"],"confidence":"High","gaps":["Physiological context of the GAP activity not yet established","Structural basis of the dual-finger mechanism not solved","Functional consequence of Rab9A effector binding unclear"]},{"year":2015,"claim":"Demonstrated the physiological consequence of SGSM2 GAP activity by showing it governs melanogenic enzyme trafficking and that Rab9A binding positions SGSM2 for this function.","evidence":"In vitro GAP assays plus loss- and gain-of-function in mouse melanocytes scoring melanogenic enzyme localization and Rab9A-dependent SGSM2 localization","pmids":["26620560"],"confidence":"High","gaps":["Mechanism linking Rab9A binding to SGSM2 membrane targeting not detailed","Quantitative relationship between Rab32/38 activity level and trafficking fidelity not mapped","Relevance beyond melanocytes untested"]},{"year":2019,"claim":"Extended SGSM2 function beyond Rab trafficking to plasma-membrane cell adhesion, linking its loss to FAK activation and EMT.","evidence":"Co-IP and immunofluorescence co-localization with E-cadherin/β-catenin plus knockdown with EMT marker and migration readouts under oestrogen/fibronectin stimulation","pmids":["30744493"],"confidence":"Medium","gaps":["No in vitro reconstitution of the E-cadherin/β-catenin interaction","Whether GAP activity is required for the adhesion role is unknown","Single-lab knockdown without rescue"]},{"year":2022,"claim":"Identified a signaling role in which SGSM2 enhances RAP1 to suppress RAS-driven MAPK and PI3K pathways, framing it as a tumor suppressor in wild-type-RAS cancer.","evidence":"Co-IP for SGSM2-RAP1 interaction, RAP1 activity assays, and overexpression with readouts of RAS activation, downstream signaling, and cancer cell phenotypes in thyroid cancer cells","pmids":["35264562"],"confidence":"Medium","gaps":["Mechanism by which SGSM2 augments RAP1 activity not defined","No reciprocal or in vitro validation of the SGSM2-RAP1 interaction","Whether the TBC GAP domain or Arg-803 contributes is untested"]},{"year":null,"claim":"How SGSM2's biochemical GAP activity toward Rab32/33B/38 mechanistically connects to its plasma-membrane adhesion and RAP1/RAS signaling roles remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model integrating RUN and TBC domains with the multiple partners","Unknown whether GAP catalysis is required for the adhesion and RAP1 functions","No unifying model across melanocyte, epithelial, and cancer contexts"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,2]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,2,4]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[1,2]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[4]}],"complexes":[],"partners":["RAB32","RAB33B","RAB38","RAB9A","CDH1","CTNNB1","RAP1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O43147","full_name":"Small G protein signaling modulator 2","aliases":["RUN and TBC1 domain-containing protein 1"],"length_aa":1006,"mass_kda":113.3,"function":"Possesses GTPase activator activity towards RAB32, RAB33B and RAB38 (PubMed:21808068, PubMed:26620560). Regulates the trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes by inactivating RAB32 and RAB38. Inhibits RAB32 and RAB38 activation both directly by promoting their GTPase activity and indirectly by disrupting the RAB9A-HPS4 interaction which is required for RAB32/38 activation (PubMed:26620560)","subcellular_location":"Cytoplasm; Melanosome","url":"https://www.uniprot.org/uniprotkb/O43147/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SGSM2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SGSM2","total_profiled":1310},"omim":[{"mim_id":"616938","title":"COFFIN-SIRIS SYNDROME 5; CSS5","url":"https://www.omim.org/entry/616938"},{"mim_id":"611418","title":"SMALL G PROTEIN SIGNALING MODULATOR 2; SGSM2","url":"https://www.omim.org/entry/611418"},{"mim_id":"611417","title":"SMALL G PROTEIN SIGNALING MODULATOR 1; SGSM1","url":"https://www.omim.org/entry/611417"},{"mim_id":"610440","title":"SMALL G PROTEIN SIGNALING MODULATOR 3; SGSM3","url":"https://www.omim.org/entry/610440"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SGSM2"},"hgnc":{"alias_symbol":["KIAA0397"],"prev_symbol":["RUTBC1"]},"alphafold":{"accession":"O43147","domains":[{"cath_id":"1.20.58.900","chopping":"5-96_125-198","consensus_level":"high","plddt":85.0433,"start":5,"end":198},{"cath_id":"2.30.29.230","chopping":"251-384_416-422","consensus_level":"high","plddt":80.8608,"start":251,"end":422},{"cath_id":"1.10.472.80","chopping":"535-545_560-565_876-1005","consensus_level":"high","plddt":93.0562,"start":535,"end":1005},{"cath_id":"-","chopping":"569-627_771-870","consensus_level":"medium","plddt":92.218,"start":569,"end":870}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43147","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43147-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43147-F1-predicted_aligned_error_v6.png","plddt_mean":70.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SGSM2","jax_strain_url":"https://www.jax.org/strain/search?query=SGSM2"},"sequence":{"accession":"O43147","fasta_url":"https://rest.uniprot.org/uniprotkb/O43147.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43147/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43147"}},"corpus_meta":[{"pmid":"21873549","id":"PMC_21873549","title":"Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.","date":"2011","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/21873549","citation_count":278,"is_preprint":false},{"pmid":"23263489","id":"PMC_23263489","title":"Exome array analysis identifies new loci and low-frequency variants influencing insulin processing and secretion.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23263489","citation_count":217,"is_preprint":false},{"pmid":"17509819","id":"PMC_17509819","title":"Identification of three novel proteins (SGSM1, 2, 3) which modulate small G protein (RAP and RAB)-mediated signaling pathway.","date":"2007","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/17509819","citation_count":54,"is_preprint":false},{"pmid":"21808068","id":"PMC_21808068","title":"RUTBC1 protein, a Rab9A effector that activates GTP hydrolysis by Rab32 and Rab33B proteins.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21808068","citation_count":53,"is_preprint":false},{"pmid":"26620560","id":"PMC_26620560","title":"RUTBC1 Functions as a GTPase-activating Protein for Rab32/38 and Regulates Melanogenic Enzyme Trafficking in Melanocytes.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26620560","citation_count":36,"is_preprint":false},{"pmid":"29608557","id":"PMC_29608557","title":"A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses.","date":"2018","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29608557","citation_count":32,"is_preprint":false},{"pmid":"21777205","id":"PMC_21777205","title":"Evidence for age as a modifier of genetic associations for lipid levels.","date":"2011","source":"Annals of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21777205","citation_count":23,"is_preprint":false},{"pmid":"35264562","id":"PMC_35264562","title":"SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/35264562","citation_count":14,"is_preprint":false},{"pmid":"33386701","id":"PMC_33386701","title":"Development and validation of a four-lipid metabolism gene signature for diagnosis of pancreatic cancer.","date":"2021","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/33386701","citation_count":13,"is_preprint":false},{"pmid":"30744493","id":"PMC_30744493","title":"Small G protein signalling modulator 2 (SGSM2) is involved in oestrogen receptor-positive breast cancer metastasis through enhancement of migratory cell adhesion via interaction with E-cadherin.","date":"2019","source":"Cell adhesion & migration","url":"https://pubmed.ncbi.nlm.nih.gov/30744493","citation_count":12,"is_preprint":false},{"pmid":"15375525","id":"PMC_15375525","title":"Characterization of RUSC1 and RUSC2 genes in silico.","date":"2004","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/15375525","citation_count":8,"is_preprint":false},{"pmid":"33392103","id":"PMC_33392103","title":"VARP and Rab9 Are Dispensable for the Rab32/BLOC-3 Dependent Salmonella Killing.","date":"2020","source":"Frontiers in cellular and infection microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/33392103","citation_count":7,"is_preprint":false},{"pmid":"31209429","id":"PMC_31209429","title":"[Detection of preoperative chemoradiotherapy sensitivity molecular characteristics of rectal cancer by transcriptome second generation sequencing].","date":"2019","source":"Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31209429","citation_count":3,"is_preprint":false},{"pmid":"37715225","id":"PMC_37715225","title":"Meta-analysis of integrated ChIP-seq and transcriptome data revealed genomic regions affected by estrogen receptor alpha in breast cancer.","date":"2023","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/37715225","citation_count":3,"is_preprint":false},{"pmid":"39895822","id":"PMC_39895822","title":"Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study.","date":"2025","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39895822","citation_count":2,"is_preprint":false},{"pmid":"38767639","id":"PMC_38767639","title":"Clinical efficacy and gene chip expression analysis of Shenzhu Guanxin recipe granules in patients with intermediate coronary lesions.","date":"2024","source":"Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan","url":"https://pubmed.ncbi.nlm.nih.gov/38767639","citation_count":0,"is_preprint":false},{"pmid":"42160392","id":"PMC_42160392","title":"Shared diagnostic biomarkers in metabolic syndrome and coronary artery disease identified by integrated bioinformatics and machine learning.","date":"2026","source":"Endocrine connections","url":"https://pubmed.ncbi.nlm.nih.gov/42160392","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11302,"output_tokens":1627,"usd":0.029156,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":8372,"output_tokens":2371,"usd":0.050568,"stage2_stop_reason":"end_turn"},"total_usd":0.079724,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"SGSM2 (and family members SGSM1/3) co-precipitate with RAP and RAB subfamily members of the small G protein superfamily, indicating physical association with these GTPases; endogenous Sgsm1 protein was localized to the trans-Golgi network by immunofluorescence microscopy in mouse Neuro2a cells.\",\n      \"method\": \"Immunoprecipitation (co-IP) of expressed cDNA constructs; immunofluorescence microscopy\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, co-IP demonstrated physical interaction with RAP/RAB GTPases and TGN localization shown by immunofluorescence, but no in vitro biochemical reconstitution or functional mutagenesis performed\",\n      \"pmids\": [\"17509819\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"RUTBC1 (SGSM2) binds Rab9A-GTP both in vitro and in cultured cells but is NOT a GAP for Rab9A. Instead, RUTBC1 functions as a GAP for Rab32 and Rab33B, stimulating GTP hydrolysis; catalysis requires Arg-803, consistent with a dual-finger mechanism. RUTBC1 also influenced Rab32 binding to its effector Varp in cells.\",\n      \"method\": \"In vitro GTPase activity assays with biochemical screening of Rab substrates; active-site mutagenesis (Arg-803); co-immunoprecipitation in cells and cell extracts; catalytically-inhibited Rab33B Q92A mutant rescue experiment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution of GAP activity, active-site mutagenesis identifying catalytic residue, and cellular validation of Rab32 effector binding in a single rigorous study\",\n      \"pmids\": [\"21808068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"RUTBC1 (SGSM2) functions as a physiological GAP for both Rab32 and Rab38 in melanocytes, regulating the trafficking of all three melanogenic enzymes (tyrosinase, Tyrp1, and dopachrome tautomerase) to melanosomes. Rab9A interaction regulates RUTBC1 localization and is required for proper melanogenic enzyme trafficking. Either excess activation or inactivation of Rab32/38 (by manipulating RUTBC1 levels) impairs melanogenic enzyme trafficking.\",\n      \"method\": \"In vitro GAP assays; loss-of-function and gain-of-function manipulations in mouse melanocytes with readout of melanogenic enzyme localization; assessment of RUTBC1 localization dependence on Rab9A\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — physiological GAP role established by multiple functional assays in melanocytes, independently extending and replicating the in vitro findings of the 2011 JBC paper\",\n      \"pmids\": [\"26620560\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SGSM2 is a plasma membrane protein that directly interacts with E-cadherin and β-catenin. SGSM2 downregulation increased phosphorylation of FAK (Y576/577), decreased expression of epithelial markers (E-cadherin, β-catenin, Paxillin), and increased mesenchymal markers (Snail, Twist-1), reducing cell adhesion and promoting cancer cell migration. Oestrogen and fibronectin treatment promoted co-localization of SGSM2 at the leading edge with phospho-FAK (Y397).\",\n      \"method\": \"Interaction: co-immunoprecipitation, co-localization by immunofluorescence; loss-of-function knockdown with readout of EMT markers and cell migration assays\",\n      \"journal\": \"Cell adhesion & migration\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, co-IP and knockdown with multiple marker readouts, but no in vitro reconstitution or structural validation\",\n      \"pmids\": [\"30744493\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"SGSM2 interacts with RAP1 and augments RAP1 activity. Activated RAP1 competitively suppresses RAS activation, thereby downregulating MAPK/ERK and PI3K/Akt signaling in thyroid cancer cells harboring wild-type RAS. Ectopic SGSM2 expression inhibited cell proliferation, migration, invasion, and tumorigenic activity in these cells.\",\n      \"method\": \"Co-immunoprecipitation to show SGSM2-RAP1 interaction; RAP1 activity assays; gain-of-function overexpression with readout of RAS activation, MAPK/ERK, PI3K/Akt signaling, and cancer cell phenotypes\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, co-IP plus GTPase activity assays and downstream pathway measurements, but no in vitro reconstitution or structural validation\",\n      \"pmids\": [\"35264562\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SGSM2 (RUTBC1) is a RUN- and TBC-domain-containing protein that acts as a GTPase-activating protein (GAP) for Rab32, Rab33B, and Rab38 (requiring catalytic Arg-803 via a dual-finger mechanism), binds Rab9A-GTP as an effector to regulate its own localization, controls melanogenic enzyme trafficking to melanosomes, interacts with RAP1 to enhance its activity and thereby competitively suppress RAS/MAPK/PI3K signaling, and associates with E-cadherin/β-catenin at the plasma membrane to modulate cell adhesion and migration.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SGSM2 (RUTBC1) is a RUN- and TBC-domain protein that operates as a GTPase-activating protein (GAP) governing Rab-dependent membrane trafficking, with additional roles in small-G-protein signaling at the plasma membrane [#1, #4]. Biochemically, it stimulates GTP hydrolysis on Rab32 and Rab33B (and Rab38), with catalysis requiring Arg-803 via a dual-finger mechanism, while binding Rab9A-GTP as an effector rather than acting as its GAP [#1]. Through this GAP activity it sets the activation state of Rab32/Rab38 in melanocytes, where its Rab9A-dependent localization controls trafficking of the melanogenic enzymes tyrosinase, Tyrp1, and dopachrome tautomerase to melanosomes; both excess activation and inactivation of Rab32/38 disrupt this trafficking [#2]. SGSM2 additionally localizes to the plasma membrane, where it associates with E-cadherin and β-catenin to maintain epithelial adhesion and restrain FAK phosphorylation and EMT-associated migration [#3], and binds RAP1 to augment its activity, competitively suppressing RAS/MAPK/ERK and PI3K/Akt signaling and tumorigenic behavior in cancer cells [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 2007,\n      \"claim\": \"Established that SGSM2 physically associates with the small-G-protein superfamily, placing it as a candidate regulator of RAP and RAB GTPases rather than an isolated protein.\",\n      \"evidence\": \"Co-IP of expressed cDNA constructs and immunofluorescence (family member Sgsm1 at the trans-Golgi network) in mouse Neuro2a cells\",\n      \"pmids\": [\"17509819\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not determine whether the association reflects GAP, effector, or scaffold function\", \"No catalytic or in vitro reconstitution data\", \"Localization shown for the Sgsm1 paralog, not SGSM2 directly\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Defined the biochemical identity of SGSM2 as a GAP, resolving which Rabs it acts on versus binds and pinpointing the catalytic residue.\",\n      \"evidence\": \"In vitro GTPase assays with Rab substrate screening, Arg-803 active-site mutagenesis, and cellular co-IP showing Rab9A-GTP binding and effects on Rab32-Varp binding\",\n      \"pmids\": [\"21808068\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological context of the GAP activity not yet established\", \"Structural basis of the dual-finger mechanism not solved\", \"Functional consequence of Rab9A effector binding unclear\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrated the physiological consequence of SGSM2 GAP activity by showing it governs melanogenic enzyme trafficking and that Rab9A binding positions SGSM2 for this function.\",\n      \"evidence\": \"In vitro GAP assays plus loss- and gain-of-function in mouse melanocytes scoring melanogenic enzyme localization and Rab9A-dependent SGSM2 localization\",\n      \"pmids\": [\"26620560\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking Rab9A binding to SGSM2 membrane targeting not detailed\", \"Quantitative relationship between Rab32/38 activity level and trafficking fidelity not mapped\", \"Relevance beyond melanocytes untested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Extended SGSM2 function beyond Rab trafficking to plasma-membrane cell adhesion, linking its loss to FAK activation and EMT.\",\n      \"evidence\": \"Co-IP and immunofluorescence co-localization with E-cadherin/β-catenin plus knockdown with EMT marker and migration readouts under oestrogen/fibronectin stimulation\",\n      \"pmids\": [\"30744493\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No in vitro reconstitution of the E-cadherin/β-catenin interaction\", \"Whether GAP activity is required for the adhesion role is unknown\", \"Single-lab knockdown without rescue\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified a signaling role in which SGSM2 enhances RAP1 to suppress RAS-driven MAPK and PI3K pathways, framing it as a tumor suppressor in wild-type-RAS cancer.\",\n      \"evidence\": \"Co-IP for SGSM2-RAP1 interaction, RAP1 activity assays, and overexpression with readouts of RAS activation, downstream signaling, and cancer cell phenotypes in thyroid cancer cells\",\n      \"pmids\": [\"35264562\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which SGSM2 augments RAP1 activity not defined\", \"No reciprocal or in vitro validation of the SGSM2-RAP1 interaction\", \"Whether the TBC GAP domain or Arg-803 contributes is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SGSM2's biochemical GAP activity toward Rab32/33B/38 mechanistically connects to its plasma-membrane adhesion and RAP1/RAS signaling roles remains unresolved.\",\n      \"evidence\": null,\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model integrating RUN and TBC domains with the multiple partners\", \"Unknown whether GAP catalysis is required for the adhesion and RAP1 functions\", \"No unifying model across melanocyte, epithelial, and cancer contexts\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RAB32\", \"RAB33B\", \"RAB38\", \"RAB9A\", \"CDH1\", \"CTNNB1\", \"RAP1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":3,"faith_total":4,"faith_pct":75.0}}